Last reviewed · How we verify
NCT03769233
Mindfulness for Emerging Adults Experiencing Anxious and/or Depressive Symptoms
NA trial testing Mindfulness-based Intervention in Depressive Symptoms in 55 participants. Completed in 1 May 2019.
1 May 2019
Quick facts
| Lead sponsor | York University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 55 |
| Start date | 14 December 2018 |
| Primary completion | 1 May 2019 |
| Estimated completion | 1 May 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Mindfulness-based Intervention
Conditions studied
- Depressive Symptoms — all drugs for Depressive Symptoms →
- Anxious Symptoms — all drugs for Anxious Symptoms →
Sponsor
York University
Who can join
Adults 18 to 29, any sex, with Depressive Symptoms or Anxious Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Emerging adults (EA; 18 to 29 years old) in Canada are among the age group with highest risk of developing mental health issues. Despite this, they experience especially long wait-times for mental health services. To date, there has been minimal research into developmentally appropriate treatment options for the EA population. Mindfulness-based interventions (MBIs) are emerging as a potential treatment to address this need. MBIs are group-based psychological treatments for coping with distress, with the goal of improving mental health. Unfortunately, these 'traditional' MBIs are very demanding in terms of time and homework and are therefore not sufficiently feasible for the demanding schedules of EA university students. Instead, recent studies suggest a role for briefer MBIs in addressing mental health symptom burden, well-being and reducing acute stress symptoms. The brevity of these interventions make them theoretically better suited for EA university populations. High quality research, including controlled clinical trials are needed to demonstrate whether MBIs can provide efficacious treatment to improve the lives of EA university students. The current study will test the efficacy of a five-week MBI baseline within-subject controlled trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03769233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness-based Intervention
Trials testing the same drug.
- NCT07351799 — Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU · NA · recruiting
- NCT07512440 — Mindfulness and Sustainable Food Choices. · NA · completed
- NCT05459896 — A Health Apps for Post-Pandemic Years for People With Physiological and Psychosocial Distress · NA · recruiting
- NCT04727710 — Testing the Effect of Mindfulness for Prostatectomy Outcomes · NA · terminated
- NCT05515172 — Resilience Intervention for Health Professionals COVID-19 · NA · completed
Other recruiting trials for Depressive Symptoms
Currently open trials in the same condition.
- NCT07299903 — IMB-Based Sleep Hygiene Education for Menopausal Women: Effects on Sleep Quality and Depression · NA · recruiting
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07241325 — Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Section · recruiting
- NCT07216326 — Our Voices Matter: Intervention for Depression in Youth · NA · recruiting
Other York University trials
Trials by the same sponsor.
- NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
- NCT07312409 — Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? · NA · not yet recruiting
- NCT07418320 — Grow Together, Thrive Together: A Feasibility Study of a Brief Relationship Intervention for Emerging Adults and Their C · NA · not yet recruiting
- NCT07351630 — Building Blocks for Child and Family Well-being · NA · recruiting
- NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03769233 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by York University
- Last refreshed: 13 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing